NABP Drug Distributor Accreditation (DDA / VAWD) — Frequently Asked Questions
The following questions address the most common issues wholesale drug distributors and 3PLs encounter when pursuing NABP Drug Distributor Accreditation (DDA), formerly known as VAWD. If your question is not answered here, schedule a free discovery session with IHS.
What is the difference between DDA and VAWD?
NABP Drug Distributor Accreditation (DDA) and Verified-Accredited Wholesale Distributors® (VAWD®) are the same program — NABP rebranded VAWD as DDA to reflect an expanded scope. If your state license or trading partner contract references VAWD accreditation, DDA satisfies that requirement. Both names appear in regulatory and commercial contexts, and NABP recognizes them interchangeably.
Which states require Drug Distributor Accreditation (DDA/VAWD)?
States that currently require or recognize DDA as part of wholesale distributor licensing include Indiana, Minnesota, Mississippi, North Dakota, Tennessee, Utah, Wisconsin, and Wyoming, among others. Requirements evolve as state legislatures and boards of pharmacy adopt new rules. IHS monitors the current state-by-state landscape and advises clients on specific requirements as part of every engagement.
Is DDA required for third-party logistics providers (3PLs)?
Yes. NABP Drug Distributor Accreditation is available to and, in many cases, required for 3PLs that store, handle, and ship prescription drugs without taking title. 3PLs are subject to the same core DDA criteria as wholesale distributors, including facility standards, DSCSA compliance, and policy requirements. Some states specifically require 3PL licensees to maintain DDA.
How long does DDA accreditation last?
NABP Drug Distributor Accreditation is issued for a 3-year term. NABP requires an annual compliance review during years 2 and 3 of the accreditation cycle. Reaccreditation requires a new on-site inspection and documentation review.
What does the NABP on-site inspection involve?
NABP conducts an on-site inspection of the physical facility as a prerequisite to granting DDA. Inspectors evaluate facility design and security, environmental controls, documentation and SOPs, personnel training records, supplier qualification programs, DSCSA compliance infrastructure, and chain-of-custody procedures. Facilities must be operational for at least 30 days before the inspection.
Does DDA require DSCSA compliance?
Yes. Drug Supply Chain Security Act (DSCSA) compliance is a core component of DDA eligibility. The transition to full electronic interoperable tracing at the package level — effective November 2024 with enforcement in 2025 — is evaluated during the DDA inspection process. IHS provides DSCSA-specific gap assessment and corrective action guidance as part of DDA engagements.
Can a new facility apply for DDA before it has been operating for 30 days?
No. NABP requires that a facility be operational in all distribution activities for at least 30 days before an on-site inspection can be scheduled. However, preparatory work — documentation development, policy writing, gap assessment — can begin before the 30-day mark. IHS often works with new facilities in the pre-operational phase to ensure readiness is achieved as quickly as possible after launch.
What happens if my facility receives findings during the NABP inspection?
If NABP identifies deficiencies, the facility must submit a corrective action plan (CAP) that addresses each finding. NABP reviews the CAP and may require additional documentation, re-inspection, or verification of corrections before granting accreditation. IHS prepares formal CAP responses for clients, ensuring each response demonstrates genuine operational correction.
How does DDA relate to DEA registration and state wholesale distributor licenses?
DDA does not replace DEA registration or state wholesale distributor licenses — it operates alongside them. Most states require both a state wholesale distributor license and DDA as separate but complementary requirements. Maintaining current DEA and state licenses in good standing is a prerequisite for DDA accreditation.
What is the role of a responsible person (RP) in DDA?
NABP DDA requires each accredited facility to designate a responsible person (RP) who is accountable for regulatory compliance, including maintaining licensure, implementing and updating SOPs, overseeing personnel training, and serving as the primary contact with NABP. The RP must demonstrate knowledge of applicable federal and state requirements and of the facility's specific operations.
How does IHS help distributors prepare for DDA accreditation?
IHS provides a structured, phased consulting engagement covering gap assessment, policy and procedure development, DSCSA compliance review, pre-inspection mock walkthrough, and post-inspection corrective action support. Thomas G. Goddard, JD, PhD — IHS's principal consultant and former Chief Operating Officer and General Counsel of URAC — is personally engaged in every engagement.
Can IHS help with both initial DDA accreditation and reaccreditation?
Yes. IHS supports both first-time DDA applicants and facilities seeking reaccreditation at the end of their 3-year cycle. Reaccreditation engagements benefit from a current-state gap assessment to identify any regulatory changes or operational drift since the initial accreditation. IHS also supports clients through the annual compliance review process in years 2 and 3.
What are the consequences of operating without required DDA accreditation?
Consequences can include denial or non-renewal of wholesale distributor licensure, regulatory enforcement action, loss of trading partner contracts that require DDA as a supplier qualification, and reputational harm. In states where DDA is a licensure requirement, operating without it may constitute an unlicensed activity with associated civil and criminal penalties.
Have a Question Not Covered Here?
IHS consults on the full range of DDA eligibility, preparation, and compliance questions. Schedule a Free Discovery Session to discuss your specific situation.